SEC Form 3 · accession 0001209191-16-145272
Neurogene Inc. · NGNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Troupin
Officer — Chief Medical Officer
Period of report
Oct 3, 2016
Accepted (ET)
Oct 6, 2016 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities are benefically owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.